Investment news

Blackstone Group Inc BX.N said it agreed to acquire genealogy provider Ancestry.com Inc from private equity rivals for $4.7 billion, including debt, placing a big bet on family-tree chasing as well as personalized medicine.

Japan’s Takeda Pharmaceutical Co Ltd (4502.T) is making final arrangements to sell its domestic over-the-counter (OTC) business to U.S. investment fund Blackstone Group Inc (BX.N), Kyodo News reported

Teladoc Health (TDOC), the global leader in virtual care, and Livongo (LVGO), the leading Applied Health Signals company – announced that they have entered into a definitive merger agreement.

Brings Together Highly Complementary Portfolios to Empower Clinicians and Patients in the Fight Against Cancer Establishes Integrated Platform of End-to-End Oncology Solutions to Address Entire Cancer Care Continuum – from Screening and Diagnosis to Care Delivery and Post-Treatment Survivorship Creates a Leading Digital Healthcare Platform that Leverages Real-World Evidence and AI, Positioning Combined Company to Favorably Disrupt Oncology Care with Software, Data and Technology Varian Shareholders to Receive $177.50 per Share in Cash, Representing a 42% Premium

Project taps DFC expertise and new partnership with DOD; Kodak’s heritage for innovation

Additional funding to support expanded mRNA-1273 clinical development plan including 30,000 participant Phase 3 COVE study conducted in collaboration with the NIH

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021. Under the agreement, the U.S. government will receive 100 million doses of BNT162, the COVID-19 vaccine candidate jointly developed by Pfizer and BioNTech, after Pfizer successfully manufactures and obtains approval or emergency use authorization from U.S. Food and Drug Administration (FDA).

This is a joint press release of the Federal Ministry of Economics and Energy and dievini Hopp Biotech holding. A list of questions and answers regarding the investment of the German Federal Government can be found at the bottom of this page.